The two-day CMO Summit has over 60 biotech Chief Medical Officers speaking in over 40 sessions. We are grateful to the support of this incredible community of R&D leadership representing biotechs of all therapeutic areas.
NEW YORK (PRWEB) December 15, 2022
The Conference Forum is pleased to announce the agenda and keynote speakers for the 11th annual Chief Medical Officer Summit 360°, the only conference dedicated to supporting the role of the Chief Medical Officer in emerging biotechs. The CMO Summit 360° will take place in Boston on April 4-5.
“The two-day CMO Summit has over 60 biotech Chief Medical Officers speaking in over 40 sessions. We are grateful to the support of this incredible community of R&D leadership representing biotechs of all therapeutic areas,” says Andrew Goldstein, Senior Conference Producer for the CMO Summit 360°.
Dr John Maraganore, Founding CEO of Alnylam Pharmaceutical is the CEO keynote. Dr Maraganore will share highlights and lessons learned from his 19 years as a CEO leading a team that conquered some very difficult drug development challenges and how he worked with his senior level R&D leadership.
The state of the drug development industry keynote address will be given by Ken Getz, MBA, Deputy Director of Sponsored Research, Tufts CSDD, and Founder of CISCRP.
The CMO Summit 360°'s Founding Advisor, Dr Elizabeth Stoner, Executive Partner at MPM Capital, will share some opening remarks as well as provide a snapshot on what investors look for in a CMO and the biotech investment landscape.
Additionally, for the first time at the CMO Summit 360°, there will be a series of fireside discussions between CMOs and their C-suite colleagues on how they communicate and collaborate cross-functionally.
Key topic areas for 2023 covered include: biotech finance and business development, trends and technologies in clinical development, regulatory best practices, organizational management, internal relationships and team building, communication strategies, professional development for CMOs and more.
The Chief Medical Officer Summit 360°brings together CMO and R&D executives to address the unique challenges associated with directing and managing all R&D functions with limited resources, while raising capital and strategizing for appropriate exits. It is the annual Boston gathering for R&D leadership networking from small to mid-size biotechs to share ideas, solutions and support.
To learn more about the event, please visit https://theconferenceforum.org/conferences/chief-medical-officer-summit/overview/
About the Conference Forum:
The Conference Forum is a life science industry research firm that develops conferences, podcasts, newsletters and webinars primarily around how to get therapeutics to patients faster. They examine and challenge the complex ecosystem of drug development and delivery, bringing ideas together from a variety of sources to help advance clinical research with common goals that are patient-focused. They are committed to creating the best content, exchange of ideas and solutions among peers, as well as providing high-quality networking. Learn more about the Conference Forum at theconferenceforum.org.